[3]Proven via independent clinical study conducted over 4 weeks on 31 participants
This is a major contrast to other research compound formats, such as our shelf-stable BPC 157 Capsules, which don't require these temperature-controlled protocols
It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
It assists your body in converting your food into energy so that you have the fuel you need to maintain yourself throughout the day
Type: Recombinant research-reagent supplier (academic and industry labs) Purity: Research-grade recombinant, batch-to-batch consistency Third-party testing: In-house QC
[DOI] [PMC free article] [PubMed] [Google Scholar] 387.Vendrell J., El Bekay R., Peral B., Garcia-Fuentes E., Megia A., Macias-Gonzalez M